Longstanding claims that one of the reasons for high drug prices in the US is the actions of pharmacy benefit management ... investigated by the Federal Trade Commission (FTC).
PBM reform represents a tremendous opportunity. It might be one of the only significant, consequential areas of true ...
The FTC called out the nation’s leading pharmacy benefit managers for inflating pharmacy costs, affecting both employers and ...
Federal Trade Commission chairman Andrew Ferguson called for eliminating legal protections that prevent presidents from ...
On December 11, 2024, a bill was introduced in the U.S. House of Representatives that, if enacted, would have substantial implications for ...
Healthcare startup Capital Rx seeing revenue surge as Congress seeks to regulate the PBM giants that profit from high drug ...
CVS Health reported $1.6 billion in profit for the fourth quarter, down from a $2 billion haul a year ago, according to its ...
The bill would allow pharmacies to decline dispensing prescriptions to people if that pharmacy would be reimbursed less than ...